About
Biologics
Areas of Focus
Categories
Biologics & BiopharmaceuticalMidwest
Team (13)
Alex Aimetti, Ph.D.
Chief Development Officer
DiaMedica Therapeutics
team_member
Ambarish Shah, Ph.D.
Chief Technology Officer
DiaMedica Therapeutics
executive
Charles Semba, M.D.
Director
DiaMedica Therapeutics
team_member
Daniel O’Connor
Director
DiaMedica Therapeutics
team_member
Dominic Cundari
Chief Commercial Officer
DiaMedica Therapeutics
team_member
Dr. Paolo Madeddu, MD
Senior Scientific Advisor and KLK1 Expert
DiaMedica Therapeutics
advisor
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
1,066
By Phase
NA: 1PHASE2/PHASE3: 1PHASE2: 2PHASE1: 2PHASE1/PHASE2: 1
By Status
COMPLETED: 5WITHDRAWN: 1RECRUITING: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06875141Lead Sponsor
DM199 for Pregnancy Complications
NAWithdrawn
Started: May 31, 2025 · Completed: May 31, 2025
NCT05065216Lead Sponsor
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
PHASE2/PHASE3Recruiting
728 participants
Started: Nov 7, 2021 · Completed: Dec 31, 2026
NCT04123613Lead Sponsor
Multiple Doses of DM199 in Patients With Chronic Kidney Disease (REDUX)
PHASE2Completed
79 participants
Started: Dec 17, 2019 · Completed: Mar 16, 2022
NCT03795389Lead Sponsor
Study to Assess PK, Safety and Tolerability in Patients With DM and CKD
PHASE1Completed
33 participants
Started: Feb 12, 2019 · Completed: Jul 21, 2019
NCT03290560Lead Sponsor
Evaluation to Assess Safety and Tolerability of DM199 in Subjects With Acute Ischemic Stroke
PHASE2Completed
92 participants
Started: Jan 19, 2018 · Completed: Jan 23, 2020
Locations (1)
Headquarters
Minnetonka, MN, United States
Map
Loading map...